Complications during the treatment of diabetic foot osteomyelitis

Suzanne A.V. van Asten, Moez Mithani, Edgar J.G. Peters, Javier La Fontaine, Paul J. Kim, Lawrence A. Lavery*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Aim To identify complications of medical treatment in patients with diabetic foot osteomyelitis (DFO). Methods We reviewed 143 records of consecutive patients admitted with DFO, confirmed by bone histopathology or culture. Complications monitored included acute kidney injuries (AKI), development of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), gastrointestinal complications, and venous catheter related complications during a 12 months follow-up period. Results Forty-seven AKI episodes were reported during follow-up; half occurred during the first hospitalization with involvement of antimicrobial therapy in 14 events (29.8%). Patients with AKI were more likely to have recurrent ulcerations (69.2% vs. 45.2%, p = 0.02), recurrent infections (38.5% vs. 17.3%, p = 0.01), and recurrent hospitalizations (43.6% vs. 28.8%, p = 0.02) during follow-up. Only 14 MRSA isolates were found in bone samples at baseline (9.8%). Resistant strains of MRSA and VRE were identified in twenty-one patients (14.7%) during follow-up. Patients re-hospitalized for infection were more likely to have resistant bacterial strains (52.6% vs. 25.8%, p = 0.02). Conclusions In this study, the rates of VRE and MRSA in bone biopsies of patients with DFO were lower than in previous reports. Acute kidney injury occurred frequently in our patient population but might not be associated with antibiotic exposure.

Original languageEnglish
Pages (from-to)58-64
Number of pages7
JournalDiabetes Research and Clinical Practice
Volume135
DOIs
Publication statusPublished - 1 Jan 2018

Cite this